Skip to content

Clinical trials

Glomerulonephritis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20203
20212
20222
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
The George Institute2
Alexion Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Jade Biosciences, Inc.1
Melbourne Health1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Swedish Orphan Biovitrum1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis14
Glomerulonephritis, IGA11
Kidney Diseases10
Renal Insufficiency, Chronic6
Urologic Diseases5
Autoimmune Diseases3
Immune System Diseases3
Nephritis3
Proteinuria3
Diabetic Nephropathies2

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.